AKT1 and cancer: Homodimers or heterodimers with other ErbB receptors results in phosphorylation of residues in the intracellular domain and then recruitment of adapter molecules responsible for activation of PI3K/AKT pathway or ERK1/2 signaling pathways involved in cancer cell proliferation and survival [4–6].